… Our study lends support to the idea that the cumulative dose of cisplatin in concurrent
chemoradiotherapy protocols for HNSCC matters. However, the question of the optimal dose and …

… cisplatin should remain standard treatment of patients with locoregionally advanced head and
neck squamous cell … oropharyngeal cancer treated with RT plus cetuximab versus cisplatin…

… cisplatin-based chemotherapy with radiation therapy in a variety of advanced stage or high-risk
settings. The term chemoradiotherapy … in patients with squamous cell cancer of the head …

… Chemoradiotherapy has been clinically indicated for patients with resectable esophageal
squamous cell … unresectable esophageal squamous cell carcinoma patients. Concurrent …

… chemoradiotherapy (CRT) over radiation alone in locally advanced non-small cell lung cancer
… with chemotherapy (CT) consisting of a cisplatin and vinorelbine regimen, in patients with …

… I study of concurrent thoracic radiotherapy with cisplatin plus vinorelbine, and the other
evaluated docetaxel consolidation therapy following concurrent chemoradiotherapy.7, 8 These …

… Prospective study of cetuximab, carboplatin, and radiation therapy for patients with locally
advanced head and neck squamous cell cancer unfit for cisplatin. Int J Radiat Oncol Biol Phys …

… in the treatment of LAHNC for concurrent chemoradiotherapy versus radiotherapy alone. A
… chemoradiotherapy compared with radiotherapy alone. This analysis identified cisplatin (…

… chemoradiotherapy with full doses of cisplatin-based chemotherapy is standard treatment for
inoperable stage III non-small cell lung cancer … reported a full dose of cisplatin (CDDP) plus …

… Carboplatin should be a reasonable option for locally advanced squamous cell cancer of
the head and neck, specially for patients unable to cisplatin and without access to concomitant …